Exploring How Albumin Supplementation Affects Serum Albumin Levels, CD8+ Lymphocyte Counts, and Interferon Gamma In Rifampicin-Resistant TB Patients
DOI:
https://doi.org/10.36497/jri.v45i3.874Keywords:
albumin, CD8+ lymphocytes, interferon-gamma, rifampicin-resistant tuberculosis, serum albumin levelsAbstract
Background: Drug-resistant tuberculosis (DR-TB) remains a global health threat, with increasing cases unresponsive to rifampicin therapy. Diagnosing rifampicin-resistant TB (RR-TB) requires a multidisciplinary approach, in which markers such as interferon-gamma (IFN-ɣ) are useful for diagnosis, monitoring, therapy evaluation, and prognosis. Hypoalbuminemia commonly accompanies TB patients, evidenced by weight loss and reduced serum albumin levels. TB infection stimulates cytokine production, which suppresses albumin synthesis and regulation, affecting both prognosis and treatment success, particularly in RR-TB. This study aimed to evaluate the role of albumin supplementation in improving serum albumin levels, CD8+ lymphocyte counts, and IFN-ɣ levels in RR-TB patients.
Methods: This true experimental study with a pre- and post-test control group design was conducted at Saiful Anwar Hospital. Thirty subjects were recruited: 10 healthy individuals (control group), 10 RR-TB patients receiving albumin supplementation (egg white extract) for 30 days (RR-TB + Albumin), and 10 RR-TB patients without supplementation (RR-TB only). Peripheral blood samples were collected before and after anti-TB drug (ATD) and albumin administration. Flow cytometry was used for analysis. Data were analyzed using SPSS and Partial Least Squares (PLS) analysis.
Results: Significant differences in albumin and IFN-ɣ levels were observed between the control and RR-TB groups before supplementation. No significant differences were found in CD8+ lymphocyte counts (P=0.402) or IFN-ɣ levels (P=0.390) between supplemented and non-supplemented RR-TB patients. However, albumin levels (P=0.003) and body weight (P=0.014) increased significantly in the supplemented group.
Conclusion: Albumin supplementation significantly increases serum albumin levels and body weight in RR-TB patients, but does not significantly affect CD8+ lymphocyte counts or IFN-ɣ levels.
Downloads
References
1. World Health Organization. Global tuberculosis report 2023. 2023.
2. Kementerian Kesehatan RI. Laporan program penanggulangan tuberkulosis 2023. Jakarta; 2024.
3. Jilani TN, Avula A, Gondal AZ, Siddiqui AH. Active tuberculosis. StatPearls, editor. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
4. Tseng SH, Cheng MA, Farmer E, Ferrall L, Kung YJ, Lam B, et al. Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity. J Immunother Cancer. 2022;10(4):e004342.
5. Pratama HA, Efendi E, Riyanti R. Pengaruh ekstrak albumin ikan gabus (channa striata) terhadap kadar IFN-γ pasien tuberkulosis paru dengan pengobatan fase intensif. e-Jurnal Pustaka Kesehatan. 2016;4(2):222–8.
6. Balaka KI, Apriyanto A, Ishar I. Hubungan indeks massa tubuh dengan kadar albumin pada penderita tuberkulosis paru yang menjalani terapi obat anti tuberkulosis (OAT) di Rumah Sakit Benyamin Guluh Kolaka. Jurnal Analis Kesehatan Kendari. 2023;5(2):65–70.
7. Hu S, Guo J, Chen Z, Gong F, Yu Q. Nutritional indices predict all cause mortality in patients with multi-/rifampicin-drug resistant tuberculosis. Infect Drug Resist. 2024;17:3253–63.
8. Liu R, Shu W, Song Y, Liu Y, Ma L, Gao M. Use of serum albumin level as a predictive marker of clinical outcomes for active tuberculosis. Ann Clin Lab Sci. 2020;50(5):681–6.
9. Ukibe NR, Ndiuwem CK, Ogbu II, Ukibe SN, Ehiaghe FA, Ikimi CG. Prognostic value of some serum protein fractions as Early Index of clinical recovery in pulmonary tuberculosis subjects. Indian Journal of Tuberculosis. 2020;67(2):167–71.
10. Janmeja AK, Aggarwal D, Dhillon R. Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions. Indian Journal of Tuberculosis. 2018;65(2):135–9.
11. Svensson EM, Dosne AG, Karlsson MO. Population pharmacokinetics of bedaquiline and metabolite M2 in patients with drug-resistant tuberculosis: The effect of time-varying weight and albumin. CPT Pharmacometrics Syst Pharmacol. 2016;5(12):682–91.
12. Sari DK, Mega JY, Harahap J. Nutrition status related to clinical improvement in AFB-positive pulmonary tuberculosis patients in primary health centres in Medan, Indonesia. Open Access Maced J Med Sci. 2019;7(10):1621–7.
13. Ganesan H, Gopinath P. Prevalence of hypoalbuminemia among tuberculosis patients receiving anti tuberculosis therapy: A cross sectional study. International Journal of Advanced Biochemistry Research. 2019;3(2):9–13.
14. Berktas M, Guducuoglu H, Bozkurt H, Onbasi KT, Kurtoglu MG, Andic S. Change in serum concentrations of interleukin-2 and interferon-γ during treatment of tuberculosis. Journal of International Medical Research. 2004;32(3):324–30.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Adrian Yusdianto, Iin Noor Chozin, Teguh Rahayu Sartono, Rezki Tantular, Syahrul Chilmi, Nanik Setijowati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
